SAT
- Product code
- SAT
- Device name
- Pulmonary Hypertension Machine Learning-Based Notification Software
- Device class
- Class 2
- 21 CFR
- 21 CFR 870.2380
- Medical specialty
- Cardiovascular
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 3
- Summaries archived here
- 2 (direct download)
- 510(k) clearances (all years, FDA)
- 3 (all years; only the last 3 years are listed here)
FDA classification definition
Pulmonary hypertension machine learning-based notification software employs machine learning techniques to suggest the likelihood of pulmonary hypertension for further referral or diagnostic follow-up.
510(k) clearances, last 3 years (3)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K253699 | 2026-08-21 | Tempus AI, Inc. | Tempus ECG-PH | FDA |
| K252360 | 2026-03-28 | Anumana, Inc. | ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm | |
| K233666 | 2024-04-05 | Analytics For Life, Inc. | CorVista System with PH Add-On |
Official FDA classification page: SAT
Classification and pathway per current FDA publications. Data from openFDA (CC0).